Evidence map›Paper›PMID 41229389›Full record

ArticleThe Analyst2025

An automated illumination system for high-throughput photopharmacology studies: a case study of ROS-sensitive Zn- and Pd-phthalocyanine-loaded liposomes.

Ali Eftekhari, Olga Lem, Alexander Efimov, Timo Laaksonen, Nikita Durandin

Abstract read
In one paragraph

Article in The Analyst, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ali EftekhariTampere University, Engineering and Natural Science, Materials Science and Environmental Engineering, Tampere, Finland. nikita.durandin@tuni.fi.ORCID http://orcid.org/0009-0005-9557-0114
Olga LemTampere University, Engineering and Natural Science, Materials Science and Environmental Engineering, Tampere, Finland. nikita.durandin@tuni.fi.ORCID http://orcid.org/0009-0004-3079-9164
Alexander EfimovTampere University, Engineering and Natural Science, Materials Science and Environmental Engineering, Tampere, Finland. nikita.durandin@tuni.fi.ORCID http://orcid.org/0000-0003-4671-3009
Timo LaaksonenTampere University, Engineering and Natural Science, Materials Science and Environmental Engineering, Tampere, Finland. nikita.durandin@tuni.fi.
Nikita DurandinTampere University, Engineering and Natural Science, Materials Science and Environmental Engineering, Tampere, Finland. nikita.durandin@tuni.fi.ORCID http://orcid.org/0000-0002-5734-7377

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-throughput approaches for studying light-activated compounds are in high demand in biomedical applications. In this work, we designed and validated a cost-effective illumination platform that is easy to fabricate, customizable, and suitable for high-throughput

Indexed as

High-Throughput Screening AssaysIndolesLiposomesOrganometallic CompoundsPalladiumReactive Oxygen SpeciesZincDrug LiberationFluoresceinsIsoindolesLightZinc CompoundsFluoresceinsfluorexonIndolesIsoindolesLiposomesOrganometallic CompoundsPalladiumphthalocyanineReactive Oxygen SpeciesZincZinc CompoundsZn(II)-phthalocyanine

Identifiers

PMID41229389
PMCPMC12612984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.